|
|
 |
|
Viewing report
|
|
|
|
Global In Vitro Diagnostics (IVD) Market Report: 2010 Edition
Koncept Analytics, Sep 2010, Pages: 43
The global IVD market has been experiencing rapid growth, inspite of the economic recession. There has been growing awareness about health and prevention of diseases among the people, which is expected to further boost the industry's performance in the coming years. Furthermore, with countries making their healthcare services more and more accessible to the people, the demand for various IVD devices is increasing.
The developed countries presently account for the bulk of the IVD market. The emerging economies although do not have a major share in the global market, but are expected to grow at faster rate in the future and offer growth opportunities in the global market. The US, Europe and Japan are the main markets for both the pharmaceuticals and IVD industries, controlling more than three-fourth of the global IVD market. In Europe, the largest markets are Germany, followed by Italy and France.
Diabetes has been one of the major segments of the IVD market. Also, diabetes is regarded as one of the fastest growing diseases in the world due to the changing lifestyle of the present era's population.
Demand within the IVD industry has been driven by the ever increasing ageing population, technological advancements and more strict disease control standards in developed countries, amongst others. The emerging economies offer immense opportunities for the further growth of the industry. The increasing insurance facilities are also expected to boost the growth of the industry in the coming years. Complying with the laws and regulations has been one of the major challenges faced by the industry.
The global IVD market has been highly consolidated, with the top eight players accounting for a major share of the market. Roche Holdings is the market leader controlling a major part of the market.
The report analysis the IVD market on a global scale and it also provides detailed information regarding the key regional markets, Europe, US as well as the one of the emerging economies, India. The report analyses the various trends and challenges being faced by the global IVD market. It profiles the four major Pharma players involved in IVD testing: Roche Holdings, Siemens AG, Abbott Laboratories and Beckman Coulter.
By combining SPSS Inc.'s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
Also available
Global In Vitro Diagnostics (IVD) Market Report: 2011 Edition
Customers who bought this item also bought
Global In Vitro Diagnostics (IVD) Market Report: 2011 Edition
In-Vitro Diagnostic (Ivd) Market (Applications, End-Users & Types) – Trends & Global Forecasts (Major & Emerging Markets – G7, Japan & Bric) (2011 – 2016)
The Future of the In-Vitro Diagnostics Market to 2016 - Increasing Diagnostic Procedures Drive Demand
Global In Vitro Diagnostic Market Analysis
In Vitro Diagnostics Market in the US
In Vitro Diagnostics Market to 2018 - Consolidation, Decentralization and Demand for Genetic Testing to Shape the Competitive Landscape
Global In vitro Diagnostics Market 2009-2013
Global In Vitro Diagnostics Market 2010-2014
Global In Vitro Diagnostics (IVD) Market Trends and Future Forecast (2009 – 2014)
Molecular Diagnostics Market Report: 2011 Edition
|
|
|
|
